Fig. 3From: Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapyHybrid EBPs that integrate cell membrane nanostructures with synthetic materials. Synthetic nanoparticles can combine with the plasma membrane to create membrane-coated EBPs. These hybrid EBPs not only have the unique characteristics of synthetic nanoparticles but also exhibit the inherent or adapted traits of the parent cellsBack to article page